Abstract

Erythroblastic islands (EBIs), discovered more than 60 years ago, are specialized microenvironments for erythropoiesis. This island consists of a central macrophage with surrounding developing erythroid cells. EBI macrophages have received intense interest in the verifications of the supporting erythropoiesis hypothesis. Most of these investigations have focused on the identification and functional analyses of EBI macrophages, yielding significant progresses in identifying and isolating EBI macrophages, as well as verifying the potential roles of EBI macrophages in erythropoiesis. EBI macrophages express erythropoietin receptor (Epor) both in mouse and human, and Epo acts on both erythroid cells and EBI macrophages simultaneously in the niche, thereby promoting erythropoiesis. Impaired Epor signaling in splenic niche macrophages significantly inhibit the differentiation of stress erythroid progenitors. Moreover, accumulating evidence suggests that EBI macrophage dysfunction may lead to certain erythroid hematological disorders. In this review, the heterogeneity, identification, and functions of EBI macrophages during erythropoiesis under both steady-state and stress conditions are outlined. By reviewing the historical data, we discuss the influence of EBI macrophages on erythroid hematopoietic disorders and propose a new hypothesis that erythroid hematopoietic disorders are driven by EBI macrophages.

Highlights

  • “Erythropoiesis is a process by which hematopoietic stem cells (HSCs) proliferate and differentiate via multiple distinct developmental stages, to eventually generate mature red blood cells (RBCs)” (Yan et al, 2017; Huang et al, 2018; Qu et al, 2018)

  • The Erythroblastic islands (EBIs), composed of a central macrophage and surrounding erythroid cells, was the first hematopoietic niche discovered by Marcel Bessis in (1958)

  • Flow cytometry and imagestream results revealed that Vcam1 and CD169 are broadly distributed on EBI macrophages, only a proportion of EBI macrophages express CD163 and Ly6C (Li et al, 2019) in mouse bone marrow (BM)

Read more

Summary

INTRODUCTION

“Erythropoiesis is a process by which hematopoietic stem cells (HSCs) proliferate and differentiate via multiple distinct developmental stages, to eventually generate mature red blood cells (RBCs)” (Yan et al, 2017; Huang et al, 2018; Qu et al, 2018) This process occurs at the erythroblastic island (EBI), which is composed of a central macrophage surrounded by developing erythroid cells (BESSIS, 1958). An’s group used the Epor-eGFPcre mouse model and a specific antibody against human EPOR, to characterize EBI macrophages (Li et al, 2019) They performed RNA sequence of the newly identified Epor+ EBI macrophages to reveal specialized functions and potential molecular mechanisms of EBI macrophages in supporting erythropoiesis. We further highlight significant unanswered questions in view of providing vital knowledge to guide understanding of this tightly regulated process in normal and disordered erythropoiesis of hematologic diseases such as βthalassemia and polycythemia vera (PV), among others

DISTINCT EBI TYPES REVEAL HETEROGENEITY OF EBI MACROPHAGES
Secretion of Growth Factors Significant for Erythropoiesis by EBI Macrophages
Senescent RBC Clearance and Iron Recycling by EBI Macrophages
Nuclei Engulfed and Digested by EBI Macrophages
EBI MACROPHAGES DRIVE ERYTHROID HEMATOPOIETIC DISORDERS
Hematopoietic phenotype of gene deletion in mouse
Findings
FUTURE PERSPECTIVES

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.